A trial of alemtuzumab after chemotherapy for chronic lymphocytic leukaemia - CLL207 MRD Eradication Study

Cancer type:

Blood cancers
Chronic leukaemia
Chronic lymphocytic leukaemia (CLL)
Leukaemia

Status:

Results

Phase:

Phase 2

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Peter Hillmen

Supported by

Leeds Institute of Clinical Trials Research, University of Leeds
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Genzyme Therapeutics
NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKE/06/038.

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

826

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

Currently rated: 5 out of 5 based on 2 votes
Thank you!
We've recently made some changes to the site, tell us what you think